NVCT

NVCT Operating Income Growth

-25.67%TTM

Period ending:

NVCT TTM Operating Income YoY %%
NVCT TTM Operating Income YoY %23.07%-77.69%
2022-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

NVCT operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 15 observations from Dec 31, 2022 to Jun 30, 2026.

Nuvectis Pharma Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-25.6715%
-34.4783%
-38.9328%
-30.3099%
-4.1155%
9.3696%
13.3205%
11.1579%
2.3286%
-13.742%
-19.0444%
-54.9419%
-67.9355%
-28.9201%
-49.1702%

Compare operating income growth

All NVCT financial metrics · NVCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.